Ads
related to: Treatment Pah- Nitric Oxide Therapy
Treat Hypoxic Respiratory Failure &
Help Increase Neonates' O2 Levels.
- Delivery System Resources
Learn About Delivery Systems And
The Available Resources.
- Alarms & Safety Features
Ensure Your Nitric Oxide
Device Includes Safety Features.
- Abrupt NO Discontinuation
Help Mitigate The Risk Of Rebound
Pulmonary Hypertension With Alarms.
- Nitric Oxide Therapy
Search results
Merck Stock Jumps After Dow Jones Stalwart Rides Its Cancer 'Star' To Another Quarterly Beat
Investor's Business Daily· 10 hours agoMerck stock popped Thursday after the Dow Jones stalwart topped Wall Street's first-quarter views on...
Medications for Pulmonary Arterial Hypertension
Verywell Health via Yahoo News· 6 months agoMedically reviewed by Femi Aremu, PharmD Pulmonary hypertension (PH) can be challenging for healthcare professionals to diagnose because of its vague...
Merck (MRK) Gets FDA Approval for New PAH Drug Winrevair
Zacks via Yahoo Finance· 1 month agoMerck MRK announced that the FDA has granted approval to its novel activin signaling inhibitor,...
Pharma Stock Roundup: ABBV & NVO's New M&As, FDA Nod to JNJ & MRK PAH Drugs
Zacks via Yahoo Finance· 1 month agoWhile AbbVie (ABBV) is set to buy Landos Biopharma, Novo Nordisk (NVO) is set to acquire Cardior...
Is Merck Moving Toward Another Blockbuster Drug Launch?
Motley Fool· 1 year agoEarlier this month, Merck (NYSE: MRK) announced that in a phase 3 clinical trial its drug candidate,...
J&J (JNJ) Submits NDA for Single Tablet Combo to Treat PAH
Zacks via Yahoo Finance· 11 months agoJ&J (JNJ) submits a new drug application for a single tablet combination therapy of macitentan and...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 13 hours agoAfter hitting a two-year high in February, biotech stocks have pulled back markedly in April. In...
Merck (MRK) Reports Detailed Data From PAH Study on Sotatercept
Zacks via Yahoo Finance· 1 year agoMerck & Co. (MRK) announces detailed data from the phase III STELLAR study of sotatercept for the...
Merck Stock Pops After Snagging Its Latest Approval; The First In A Possible $10 Billion...
Investor's Business Daily· 1 month agoMerck stock popped Wednesday, pacing the Dow Jones industrials, after winning Food and Drug...
Merck (MRK) Posts Positive Results From PAH Drug Study
Zacks via Yahoo Finance· 2 years agoMerck's (MRK) sotatercept meets primary and secondary endpoints in a phase III study in pulmonary...
Ads
related to: Treatment Pah
